Michail Vikelis

1.4k total citations
63 papers, 977 citations indexed

About

Michail Vikelis is a scholar working on Psychiatry and Mental health, Pathology and Forensic Medicine and Physiology. According to data from OpenAlex, Michail Vikelis has authored 63 papers receiving a total of 977 indexed citations (citations by other indexed papers that have themselves been cited), including 51 papers in Psychiatry and Mental health, 35 papers in Pathology and Forensic Medicine and 16 papers in Physiology. Recurrent topics in Michail Vikelis's work include Migraine and Headache Studies (49 papers), Trigeminal Neuralgia and Treatments (30 papers) and Sympathectomy and Hyperhidrosis Treatments (12 papers). Michail Vikelis is often cited by papers focused on Migraine and Headache Studies (49 papers), Trigeminal Neuralgia and Treatments (30 papers) and Sympathectomy and Hyperhidrosis Treatments (12 papers). Michail Vikelis collaborates with scholars based in Greece, United States and Italy. Michail Vikelis's co-authors include Dimos D. Mitsikostas, Alan M. Rapoport, Emmanouil V. Dermitzakis, Andreas A. Argyriou, DD Mitsikostas, Lοukianos S. Rallidis, Demosthenes B. Panagiotakos, Maria Zolindaki, Dimitrios Th. Kremastinos and Efthimios Dardiotis and has published in prestigious journals such as SHILAP Revista de lepidopterología, Neurology and Atherosclerosis.

In The Last Decade

Michail Vikelis

57 papers receiving 943 citations

Peers

Michail Vikelis
Ruozhuo Liu China
Luisa Fofi Italy
Jong‐Hee Sohn South Korea
Teshamae Monteith United States
Yngve Hallström United States
Alejandro Labastida‐Ramírez Netherlands
Lars Neeb Germany
Hille Koppen Netherlands
Luc Herroelen Belgium
G.M. Terwindt Netherlands
Ruozhuo Liu China
Michail Vikelis
Citations per year, relative to Michail Vikelis Michail Vikelis (= 1×) peers Ruozhuo Liu

Countries citing papers authored by Michail Vikelis

Since Specialization
Citations

This map shows the geographic impact of Michail Vikelis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michail Vikelis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michail Vikelis more than expected).

Fields of papers citing papers by Michail Vikelis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michail Vikelis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michail Vikelis. The network helps show where Michail Vikelis may publish in the future.

Co-authorship network of co-authors of Michail Vikelis

This figure shows the co-authorship network connecting the top 25 collaborators of Michail Vikelis. A scholar is included among the top collaborators of Michail Vikelis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michail Vikelis. Michail Vikelis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Argyriou, Andreas A., Emmanouil V. Dermitzakis, Georgia Xiromerisiou, et al.. (2025). Effects of Pausing and Re‐Initiating Fremanezumab After Continuous 24‐Month Treatment for Preventing Difficult‐To‐Treat Migraine: Prospective, Multicenter, Real‐World Data From the GRASP Study Group. European Journal of Neurology. 32(8). e70327–e70327.
2.
Dermitzakis, Emmanouil V., Michail Vikelis, Georgia Xiromerisiou, et al.. (2024). Nine-Month Continuous Fremanezumab Prophylaxis on the Response to Triptans and Also on the Incidence of Triggers, Hypersensitivity and Prodromal Symptoms of Patients with High-Frequency Episodic Migraine. Journal of Clinical Medicine. 13(2). 386–386. 4 indexed citations
3.
4.
5.
6.
Vikelis, Michail, et al.. (2023). Genetic Variability in Vitamin D Receptor and Migraine Susceptibility: A Southeastern European Case-Control Study. Neurology International. 15(3). 1117–1128. 1 indexed citations
7.
Vikelis, Michail, Emmanouil V. Dermitzakis, Georgia Xiromerisiou, et al.. (2023). Effects of Fremanezumab on Psychiatric Comorbidities in Difficult-to-Treat Patients with Chronic Migraine: Post Hoc Analysis of a Prospective, Multicenter, Real-World Greek Registry. Journal of Clinical Medicine. 12(13). 4526–4526. 8 indexed citations
8.
Mitsikostas, Dimos D., Anastasios Orologas, Efthimios Dardiotis, et al.. (2023). A Prospective, Observational Study Assessing Effectiveness, Safety, and QoL of Greek Patients with Multiple Sclerosis Under Treatment with Fingolimod. Advances in Therapy. 40(5). 2217–2233. 3 indexed citations
9.
10.
Vikelis, Michail, et al.. (2021). VDR Gene Polymorphisms and Cluster Headache Susceptibility: Case–Control Study in a Southeastern European Caucasian Population. Journal of Molecular Neuroscience. 72(2). 382–392. 10 indexed citations
11.
Vikelis, Michail, Vasileios Siokas, Emmanouil T. Dermitzakis, et al.. (2021). Evidence That HFE H63D Variant Is a Potential Disease Modifier in Cluster Headache. Journal of Molecular Neuroscience. 72(2). 393–400. 4 indexed citations
12.
Vikelis, Michail, et al.. (2018). Sustained onabotulinumtoxinA therapeutic benefits in patients with chronic migraine over 3 years of treatment. The Journal of Headache and Pain. 19(1). 87–87. 27 indexed citations
13.
Vikelis, Michail, et al.. (2018). A new era in headache treatment. Neurological Sciences. 39(S1). 47–58. 15 indexed citations
14.
Vikelis, Michail, et al.. (2017). Reliability and Validity of the Greek Migraine Disability Assessment (MIDAS) Questionnaire. PharmacoEconomics - Open. 2(1). 77–85. 14 indexed citations
15.
Vikelis, Michail & Alan M. Rapoport. (2016). Cluster headache in Greece: an observational clinical and demographic study of 302 patients. The Journal of Headache and Pain. 17(1). 88–88. 31 indexed citations
16.
Deligianni, Christina, Michail Vikelis, & Dimos D. Mitsikostas. (2012). Depression in headaches. Current Opinion in Neurology. 25(3). 277–283. 15 indexed citations
17.
Vikelis, Michail, et al.. (2009). Apraxia related with subcortical lesions due to cerebrovascular disease. Acta Neurologica Scandinavica. 122(1). 9–14. 7 indexed citations
18.
Konstantopoulos, Kostas, Michail Vikelis, J. Anthony Seikel, & Dimos D. Mitsikostas. (2009). The existence of phonatory instability in multiple sclerosis: an acoustic and electroglottographic study. Neurological Sciences. 31(3). 259–268. 31 indexed citations
19.
Vikelis, Michail & Dimos D. Mitsikostas. (2007). The Role of Glutamate and its Receptors in Migraine. CNS & Neurological Disorders - Drug Targets. 6(4). 251–257. 103 indexed citations
20.
Vikelis, Michail, et al.. (2005). Headache attributed to unruptured saccular aneurysm, mimicking hemicrania continua. The Journal of Headache and Pain. 6(3). 156–158. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ruozhuo Liu Breakdown of academic impact, for papers by Luisa Fofi Breakdown of academic impact, for papers by Jong‐Hee Sohn Breakdown of academic impact, for papers by Teshamae Monteith Breakdown of academic impact, for papers by Yngve Hallström Breakdown of academic impact, for papers by Alejandro Labastida‐Ramírez Breakdown of academic impact, for papers by Lars Neeb Breakdown of academic impact, for papers by Hille Koppen Breakdown of academic impact, for papers by Luc Herroelen Breakdown of academic impact, for papers by G.M. Terwindt
Rankless by CCL
2026